Differential association of serum lipids with diabetic retinopathy and diabetic macular edema

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7464-7469

  Benarous, Rehab ^a   Sasongko, Muhammad B ^a,b   Qureshi, Salmaan ^a   Fenwick, Eva ^a   Dirani, Mohamed ^a   Wong, Tien Y ^a,c   Lamoureux, Ecosse L ^a,c  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VISUAL SYSTEM PARAMETERS; BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA MACULA EDEMA; RETINA MACULA LUTEA;

AGED; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MACULA LUTEA; MACULAR EDEMA; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TRIGLYCERIDES;

EID: 84856369864     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7598     Document Type: Article

References (21)

1. Cheung N, Mitchell P, Wong YT. Diabetic retinopathy. The Lancet. 2010;376(9735):124-136.
2. Klein R, Klein BE. Are individuals with diabetes seeing better?-a long-term epidemiological perspective. Diabetes. 2010;59:1853-1860.
3. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema. Diabetes Care. 2003;26(9):2653-2664.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):9.
5. Matthews D, Stratton I, Aldington S, Holman R, Kohner E. Risks for progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004;122:1631-1640.
6. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115:1869-1875.
7. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141:446-455.
8. Sasongko BM, Wong YT, Nyugyn TT, et al. Serum apolipoprotein AI and B are stronger predictors of diabetic retinopathy than traditional lipids. Diabetes Care. 2011;34(2):474-479.
9. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004;53(11):2883-2892.
10. Raman R, Rani PK, Kulothungan V, Rachepalle SR, Kumaramanickavel G, Sharma T. Influence of serum lipids on clinically signif-icant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology. 2010;117:766-772.
11. The ACCORD study group and the ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233-244.
12. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci. 2005;46(7):2328-2333.
13. Massin P, Girach A, Erginay A, Gaudric A. Optical coherence tomography: a key to the future management of patients with diabetic macular oedema. Acta Ophthalmol Scand. 2006;84(4): 466-474.
14. Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26(6):1731-1737.
15. Landmesser U, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost. 2000;26(5):529-538.
16. Schalkwijk CG, Stehouwer CDA. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci. 2005; 109(2):143-159.
17. Chowdhury T, Hopkins D, Dodson PM, Vafidis GC. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? Eye 2002;16(6):689-693.
18. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999;14(4):223-232.
19. Cunha-Vaz J, Faria de Abreu JR, Campos AJ. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol. 1975;59(11): 649-656.
20. Klein R, Sharrett AR, Klein BEK, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: The Atherosclerosis Risk in Communities Study. Ophthalmology. 2002;109(7):1225-1234.
21. Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007;370(9600): 1687-1697.